04/07-2012 08:10:56: (CLAVIS) Clavis Pharma ASA : Mandatory notification of trade

J&J Future Invest AS, a company partly owned by Hilde Furberg, a board member of
Clavis Pharma ASA, has bought 3,500 shares at an average price of NOK 58.00.


After this transaction J&J Future Invest AS owns 3,500 shares in Clavis Pharma
ASA.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


[HUG#1624002]

Ekstern link: http://www.newsweb.no/index.jsp?messageId=308616

Nyheten er levert av OBI.